Oncoinvent ASA (KLDVK) — Cash Flow Quality Index
Oncoinvent ASA (KLDVK) has a Cash Flow Quality Index of -0.56x as of December 2023. Operating cash flow of Nkr-40.23 Million is below net income of Nkr72.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Oncoinvent ASA (KLDVK) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oncoinvent ASA Cash Flow Quality Index (2021–2023)
Historical Cash Flow Quality Index for Oncoinvent ASA across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KLDVK cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Oncoinvent ASA (2021–2023)
Year-by-year earnings quality comparison for Oncoinvent ASA. For live market cap and the full company financial profile, see KLDVK company net worth.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.56x | Nkr-40.23 Million | Nkr72.41 Million | ▼ -949.1% |
| 2021 | 0.07x | Nkr130.66K | Nkr2.00 Million | — |